CHEA,Chenghe Acquisition Co. | Financials

Financials

CHEA

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Chenghe Acquisition Co.CHEA

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Chenghe Acquisition Co. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses.

The company intends to identify business opportunities in the field of financial technology or technology-enabled financial service companies, including artificial intelligence, big data, and cloud and blockchain-related initiatives in Asian markets.

Chenghe Acquisition Co. was founded in 2021 and is based in Singapore.

Latest News >

Market Chatter: Wells Fargo Leaves Net-Zero Banking Alliance

Dec 20, 2024

10:18 AM EST, 12/20/2024 (MT Newswires) -- Wells Fargo ( WFC ) is ending its membership in climate finance group Net-Zero Banking Alliance, Bloomberg reported Friday, quoting a statement from the bank. Wells Fargo ( WFC ) didn't give an explanation for the decision, the report said. Bloomberg reported that financial firms have seen increasing pressure from US Republican lawmakers,...

Becton Dickinson & Co Insider Sold Shares Worth $633,811, According to a Recent SEC Filing

Dec 20, 2024

10:21 AM EST, 12/20/2024 (MT Newswires) -- Michael David Garrison, EVP & President, Medical, on December 19, 2024, sold 2,838 shares in Becton Dickinson ( BDX ) & Co (BDX) for $633,811. Following the Form 4 filing with the SEC, Garrison has control over a total of 6,141 shares of the company, with 6,141 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/10795/000106299324020955/xslF345X05/form4.xml...

Apollomics Ends Phase 3 Uproleselan Trial in Acute Myeloid Leukemia; Shares Fall

Dec 20, 2024

10:20 AM EST, 12/20/2024 (MT Newswires) -- Apollomics ( APLM ) shares were down more than 13% in recent Friday trading after the company said it will terminate its phase 3 study in relapsed or refractory acute myeloid leukemia, which did not demonstrate favorable benefit for uproleselan. Chief Executive Guo-Liang Yu said the results were expected because a global phase...

Canada's anti-money laundering agency plans scorecard to improve monitoring, sources say

Dec 20, 2024

TORONTO, Dec 20 (Reuters) - Canada's anti-money laundering agency is looking to introduce a system that gives financial institutions and other businesses real-time feedback through scorecards, two sources said, as the regulator ramps up initiatives to tackle financial crime. The proposed reporting system follows stricter financial crime penalties in Canada announced earlier this week after the country's No. 2 bank...